Biliary Atresia and Post-hepatoportoenterostomy
Clinical research in pediatric hepatobiliary disease includes studies in children with biliary atresia after a successful Kasai procedure, with attention to liver transplantation, portal hypertension, and progression to end-stage liver disease.
- Hepatic encephalopathy
- Variceal bleeding
- Ascites
- Pediatric end-stage liver disease
Research activity in this area centers on clinical outcomes relevant to long-term liver health in a pediatric population with chronic biliary obstruction.
Primary Biliary Cholangitis
Studies in primary biliary cholangitis focus on chronic cholestatic liver disease, with outcomes linked to alkaline phosphatase, bilirubin, and other biochemical markers of biliary injury.
- Alkaline phosphatase
- Gamma-glutamyl transferase
- Transaminases
- Serum bilirubin
Additional interest includes noninvasive measures of liver fibrosis and established disease severity scores used in PBC monitoring.
Autoimmune and Fibrotic Liver Disease
Clinical research also addresses the broader management of autoimmune cholangitis and fibrotic liver disease, with emphasis on biochemical response and markers associated with chronic cholestasis.
- Liver fibrosis assessment
- Noninvasive elastography
- ELF score
- GLOBE score
These studies reflect a therapeutic interest in conditions where persistent bile flow impairment contributes to progressive liver injury.
Severe Alcohol-Associated Hepatitis
Research in severe alcohol-associated hepatitis focuses on acute inflammatory liver injury and disease progression in patients with advanced alcohol-related liver damage.
- Alcohol-related hepatitis
- Disease progression
- Inflammatory liver injury
- Cholestatic dysfunction
This area extends the sponsor’s clinical interest into severe liver disorders with significant risk of deterioration and poor hepatic outcomes.
